HC Wainwright initiates Ionis with Buy rating and $45 target, citing strong pipeline, solid revenue, and key clinical ...
H.C. Wainwright initiated coverage of Ionis Pharmaceuticals (IONS) with a Buy rating and $45 price target Ionis is a commercial-stage biotech ...
Fintel on MSN11h
HC Wainwright & Co. Initiates Coverage of Ionis Pharmaceuticals (IONS) with Buy RecommendationFintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Ionis Pharmaceuticals (NasdaqGS:IONS) with a ...
About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...
Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo Bayer said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback